NSE
Mankind Pharma LimitedMANKIND
Mankind Pharma is a fast-growing domestic-focused pharma & consumer-health company.
| Key products | Branded generics and consumer products (Manforce, Prega News, Gas-O-Fast). |
|---|---|
| Geography | India. |
| Competitors | Sun Pharma, Alkem, Cipla. |
AI-generated overview — verify before relying on it.
Net institutional flow
+₹445.9 Cr
Institutional buyers
19 in / 1 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ALKEM | +₹1,013.7 Cr | 13 | — | — | -2 | 6 |
| 2 | MANKINDThis | — | — | — | — | — | — |
| 3 | CIPLA | — | — | — | — | +19 | 44 |
| 4 | DRREDDY | — | — | — | — | +20 | 46 |
| 5 | SUNPHARMA | — | — | — | — | +15 | 45 |
| 6 | TORNTPHARM | — | — | — | — | — | — |
| 7 | LUPIN | — | — | — | — | — | — |
| 8 | ZYDUSLIFE | — | — | 1 | +1 | — | — |
| 9 | AUROPHARMA | — | — | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-15FilingMankind Pharma Limited has informed the Exchange about Schedule of meetInvestor Call
- 2026-06-10Filing Ramesh Juneja has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities andShareholding Disclosure
- 2026-06-08FilingMankind Pharma Limited has informed the Exchange regarding Cessation of Mr Prateek Dubey as SMP of the companyManagement
- 2026-06-08FilingMankind Pharma Limited has informed the Exchange regarding Appointment of Mr Nilesh Kulkarni as SMP of the comManagement
- 2026-06-08FilingMankind Pharma Limited has informed the Exchange regarding allotment of 86778 securities pursuant to ESOP/ESPSAllotment of Securities
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF → - 3
- 2
- 2Allotment of SecuritiesNeutral
allotment of 86778 securities pursuant to ESOP/ESPS at its meeting held on Jun 08, 2026
Source PDF →
No bulk/block deals for MANKIND in this window.
Results & transcripts
News & chatter on MANKIND
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.